| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/27/2004 | EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 10/27/2004 | EP1315728B1 Process for the preparation of vitronectin receptor antagonists |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP1253906B1 Cosmetic preparations containing waltheria indica extracts and ferulic acid |
| 10/27/2004 | EP1244457B1 Use of modulators of annexin for the manufacture of a medicament for the treatment and/or prevention of arthritis and arthritic diseases |
| 10/27/2004 | EP1150952B1 Indole derivatives and their use as mcp-1 receptor antagonists |
| 10/27/2004 | EP1141022B1 Serine protease inhibitor |
| 10/27/2004 | EP1107777B1 Stabilized pharmaceutical composition in lyophilized form |
| 10/27/2004 | EP1085858B1 Transdermal therapeutic system for the administration of candesartan |
| 10/27/2004 | EP1037629B1 Combination of a retinoic acid metabolism blocking agent and a tocophereol |
| 10/27/2004 | EP1027027A4 Therapeutic method |
| 10/27/2004 | EP0970073B1 Process for preparing eprosartan |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | EP0831877B1 Metabolic effects of certain glutathione analogs |
| 10/27/2004 | EP0813544B1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 10/27/2004 | EP0763052B1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 10/27/2004 | CN1541278A Novel molecular target for neurotoxicity |
| 10/27/2004 | CN1541275A Glycoprotein and process for producing same |
| 10/27/2004 | CN1541266A FCE fusion proteins for treatment of allergy and asthma |
| 10/27/2004 | CN1541265A Identification of DNA variant associated with adult type hypolactasia |
| 10/27/2004 | CN1541222A Antibodies to non-functional P 2 Chi 7 receptor diagnosis and treatment of cancers and other conditions |
| 10/27/2004 | CN1541219A Tricyclic imidazopyridines |
| 10/27/2004 | CN1541217A Chemical compounds |
| 10/27/2004 | CN1541216A 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands |
| 10/27/2004 | CN1541214A Novel compounds |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541210A Arylsulfonyl derivatives with 5-HT6 receptor affinity |
| 10/27/2004 | CN1541208A 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/27/2004 | CN1541110A Methods for sterilizing prepns of monoclonal immunoglobulins |
| 10/27/2004 | CN1541109A Inhibitors of HER3 activity |
| 10/27/2004 | CN1541107A Growth factor complex |
| 10/27/2004 | CN1541102A Somatostain agonists |
| 10/27/2004 | CN1541098A Combination therapy for treatment of cancer |
| 10/27/2004 | CN1541097A 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 10/27/2004 | CN1541093A Novel use of combined 5-HI1A agonists and selective serotonin reuptake inhibitors |
| 10/27/2004 | CN1539834A Method for preparing handy amino-tetrahydrofurans or its salts |
| 10/27/2004 | CN1539832A Process for preparing oxazolines from tetrahydrofurans |
| 10/27/2004 | CN1539407A Solid powder preparaton from liposome of Hypocrellin and producing method |
| 10/27/2004 | CN1172949C Testosterone derivative |
| 10/27/2004 | CN1172932C Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl-protein transferase |
| 10/27/2004 | CN1172930C PDE IV inhibiting pyridine derivatives |
| 10/27/2004 | CN1172929C Substituted indoles for modulating NFKB activity |
| 10/27/2004 | CN1172927C Alkoxy derivative of safrole oxide 2-alkoxy-piperony ethanol and its prepn and application |
| 10/27/2004 | CN1172918C Isothizole derivatives useful anticancer agents |
| 10/27/2004 | CN1172718C Dendritic cell stimulatory factor |
| 10/27/2004 | CN1172699C Chinese medicine for treating syringomyelia |
| 10/27/2004 | CN1172684C Nucleic acid oral powder and its production method |
| 10/27/2004 | CN1172672C Alpha-ketoamide multicatalytic protease inhibitors |
| 10/27/2004 | CN1172668C Use of chelerythrine in prepn. of medicine |
| 10/27/2004 | CN1172665C Combined medicinal preparation of sodium/hydrogen exchange-pump inhibitor and medicine for treatment of angiocardiopathy |
| 10/27/2004 | CN1172649C Process for the manufacture of liquid filled capsules |
| 10/26/2004 | US6809204 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 10/26/2004 | US6809189 Apoptin-associating protein |
| 10/26/2004 | US6809119 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 10/26/2004 | US6809116 Materials and methods for the treatment of depression |
| 10/26/2004 | US6809115 Mixture has a synergistic, weight loss effect |
| 10/26/2004 | US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection |
| 10/26/2004 | US6809111 Antiinflammatory agents; analgesics |
| 10/26/2004 | US6809108 Selective muscarinic m3 receptor antagonts; reduced side effects |
| 10/26/2004 | US6809106 Antiproliferation agents; such as 4-(2-methoxyphenoxy)-anilino-3-chloro-6,7-dimethoxyquinoline |
| 10/26/2004 | US6809103 E-ring expanded camptothecin derivatives |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809096 Such as 11-methoxy-7h-pyrido(4,3,2-de)(1,7)phenanthroline-7-one; antitumor agents |
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
| 10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 10/26/2004 | US6809087 Sodium salt of 2-hydroxy-5-((4-(3-(4-((2-methyl-1h-imidazo-(4,5-c)pyridin-1-yl)methyl)-1 -piperidinyl)-3-oxo-1-phenyl-1-propenyl)phenyl)azo)benzoic acid; inflammatory bowel disease |
| 10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
| 10/26/2004 | US6808912 For diagnosis/therapy of inflammation, cancer, arteriosclerosis, and psoriasis |
| 10/26/2004 | US6808902 Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| 10/26/2004 | US6808892 Inositolphosphoryl-ceramide (ipc) synthase; antifungal targets; drug screening; genetic engineering |
| 10/26/2004 | US6808884 Intercalation compound for use in the diagnosis and detection of genetic disorders |
| 10/26/2004 | US6808877 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection |
| 10/26/2004 | CA2395217C Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 10/26/2004 | CA2294247C Antioxidant enhancement of therapy for hyperproliferative conditions |
| 10/26/2004 | CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 10/26/2004 | CA2127411C Tricyclic derivatives |
| 10/26/2004 | CA2127214C New use of beta-naphtoquinone derivatives and of their salts for the production of a medicament which accelerate the growth of endothelial cells to inhibit no synthtases |
| 10/26/2004 | CA2080462C Therapeutic uses of actin-binding compounds |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/21/2004 | WO2004089967A1 HETEROARYL 5-THIO-β-D-GLUCOPYRANOSIDE DERIVATIVES AND REMEDIES FOR DIABETES CONTAINING THE SAME |
| 10/21/2004 | WO2004089966A1 METHOD FOR SELECTIVE PREPARATION OF HETEROARYL 5-THIO- β-D-ALDOHEXOPYRANOSIDE |
| 10/21/2004 | WO2004089956A1 Novel amino acid dysiherbaine |
| 10/21/2004 | WO2004089936A1 Heteroarylsulfonanilide derivative and medicinal composition containing the same |
| 10/21/2004 | WO2004089933A1 Novel crystal of fluorobenzamide derivative |
| 10/21/2004 | WO2004089919A1 Cyclohexanecarboxamido derivative |
| 10/21/2004 | WO2004089918A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 10/21/2004 | WO2004089819A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 10/21/2004 | WO2004089818A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 10/21/2004 | WO2004089430A1 New dressing material promoting recovery of skin wound |
| 10/21/2004 | WO2004089417A1 Drug-enclosing multilayer structure particulate and process for producing the same |
| 10/21/2004 | WO2004089412A1 Specific nad(p)h oxidase inhibitor |
| 10/21/2004 | WO2004089369A2 Methods and means for treating protein conformational disorders |
| 10/21/2004 | WO2004089356A2 Targeted bone marrow protection agents |
| 10/21/2004 | WO2004071481B1 Melanogenesis inhibitor and skin preparation containing the same |
| 10/21/2004 | WO2004009556A9 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 10/21/2004 | WO2003102197A8 Transgenic plants with controlled distribution of a trait to progeny |
| 10/21/2004 | WO2003097163A3 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions |
| 10/21/2004 | WO2003093793A3 Binary or polynary targeting and uses thereof |